Use of alpha 7 nicotinic acetylcholine receptor agonists

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11311525
APP PUB NO 20170348294A1
SERIAL NO

15686919

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns the use of certain alpha 7 nicotinic acetylcholine receptor agonist for the facilitation of emergence from general anesthesia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NOVARTIS AG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fendt, Markus Basel, CH 4 2
Feuerbach, Dominik Basel, CH 40 275
Finnema, Sjoerd Johannes Stockholm, SE 2 1
Halldin, Christer Stockholm, SE 11 19
Johns, Donald Cambridge, US 23 16
Lopez-Lopez, Cristina Basel, CH 11 10
McAllister, Kevin Hall Basel, CH 10 8
Sovago, Judit Basel, CH 6 2
Weiss, Markus Basel, CH 46 463

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 26, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 26, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 26, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00